<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Training Together, Diagnosing Better: Federated Learning for Collagen VI-Related Dystrophies - Health AI Hub</title>
    <meta name="description" content="This paper presents a groundbreaking application of Federated Learning (FL) to address the diagnostic challenges of rare diseases, specifically collagen VI-rela">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Training Together, Diagnosing Better: Federated Learning for Collagen VI-Related Dystrophies</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.16876v1" target="_blank">2512.16876v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Astrid Brull, Sara Aguti, V√©ronique Bolduc, Ying Hu, Daniel M. Jimenez-Gutierrez, Enrique Zuazua, Joaquin Del-Rio, Oleksii Sliusarenko, Haiyan Zhou, Francesco Muntoni, Carsten G. B√∂nnemann, Xabi Uribe-Etxebarria
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI, cs.CV, cs.DC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.16876v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.16876v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents a groundbreaking application of Federated Learning (FL) to address the diagnostic challenges of rare diseases, specifically collagen VI-related dystrophies (COL6-RD), where data scarcity and privacy hinder traditional ML approaches. By enabling collaborative model training across decentralized datasets from two international organizations using the Sherpa.ai platform, the researchers developed an ML model that accurately classifies COL6-RD pathogenic mechanisms from immunofluorescence images. This FL-driven model achieved a superior F1-score of 0.82, significantly outperforming isolated institutional models and demonstrating enhanced diagnostic utility and generalizability.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is critically important for rare disease diagnosis, offering a privacy-preserving and collaborative method to overcome the fundamental data limitations. It enables the development of more accurate and generalized diagnostic tools for conditions like COL6-RD, directly benefiting patients through improved, faster, and more reliable diagnoses.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research develops an AI-powered diagnostic model for rare diseases (COL6-RD) using Federated Learning. Federated Learning is crucial here as it enables collaborative model training across decentralized datasets while preserving patient data privacy, overcoming a major hurdle for AI adoption in healthcare, especially for rare conditions. The application is a diagnostic tool that classifies pathogenic mechanisms from immunofluorescence microscopy images, leading to more accurate diagnoses and aiding in clinical decision-making, genetic counseling, and research into disease mechanisms.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Traditional Machine Learning for rare disease diagnosis (e.g., COL6-RD) is severely limited by data scarcity, fragmentation, and strict privacy/regulatory obstacles.</li>
                    
                    <li>Federated Learning (FL) provides a robust solution by allowing collaborative model training across decentralized datasets without centralizing sensitive patient information.</li>
                    
                    <li>The study implemented a novel global FL initiative leveraging the Sherpa.ai FL platform across two international organizations.</li>
                    
                    <li>The model utilized collagen VI immunofluorescence microscopy images derived from patient fibroblast cultures as input data.</li>
                    
                    <li>It successfully classified patient images into three primary pathogenic mechanism groups for COL6-RD: exon skipping, glycine substitution, and pseudoexon insertion.</li>
                    
                    <li>The FL model achieved a high F1-score of 0.82, demonstrating a significant improvement over single-organization models (F1-scores ranging from 0.57 to 0.75).</li>
                    
                    <li>The results affirm that FL substantially enhances diagnostic utility and generalizability, offering a pathway to interpret variants of uncertain significance and guide sequencing strategies for novel pathogenic variants.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a global Federated Learning (FL) framework using the Sherpa.ai FL platform. This involved training a Machine Learning model collaboratively across two distinct international organizations, where patient data remained local and private. The model's input comprised collagen VI immunofluorescence microscopy images obtained from patient-derived fibroblast cultures. The objective of the ML model was to classify these images into three specific pathogenic mechanisms associated with COL6-RD: exon skipping, glycine substitution, and pseudoexon insertion.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is that the Federated Learning model achieved a robust F1-score of 0.82 in classifying the pathogenic mechanisms of COL6-RD from immunofluorescence images. This performance markedly surpassed that of models trained in isolation within single organizations, which yielded F1-scores between 0.57 and 0.75. The FL approach successfully demonstrated a substantial improvement in diagnostic utility and generalizability.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This approach holds significant clinical impact by enabling more accurate and generalizable diagnosis of rare diseases like COL6-RD, overcoming existing data privacy and fragmentation barriers. It provides a scalable and privacy-compliant framework for international collaboration in medical AI development. Clinically, it can improve diagnostic precision, aid in interpreting variants of uncertain significance (VUS) in COL6 genes, and optimize the prioritization of sequencing strategies to identify novel pathogenic variants, ultimately leading to better patient management.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract primarily highlights the inherent limitations of traditional ML for rare diseases (data scarcity, fragmentation, privacy/regulatory obstacles) that FL aims to overcome. It does not explicitly state limitations or caveats regarding the specific Federated Learning solution presented in this paper.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors anticipate that this FL approach will support the interpretation of variants of uncertain significance (VUS) related to COL6-RD. Furthermore, it is expected to guide the prioritization of sequencing strategies, facilitating the identification of novel pathogenic variants. The success of this initiative also implies a broader applicability of FL to other rare diseases facing similar diagnostic and data sharing challenges.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neuromuscular Disorders</span>
                    
                    <span class="tag">Rare Genetic Diseases</span>
                    
                    <span class="tag">Clinical Diagnostics</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Genetics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Federated Learning</span>
                    
                    <span class="tag tag-keyword">Rare Diseases</span>
                    
                    <span class="tag tag-keyword">Collagen VI-Related Dystrophies</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Immunofluorescence Microscopy</span>
                    
                    <span class="tag tag-keyword">Privacy-Preserving AI</span>
                    
                    <span class="tag tag-keyword">Diagnostic Utility</span>
                    
                    <span class="tag tag-keyword">F1-score</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The application of Machine Learning (ML) to the diagnosis of rare diseases, such as collagen VI-related dystrophies (COL6-RD), is fundamentally limited by the scarcity and fragmentation of available data. Attempts to expand sampling across hospitals, institutions, or countries with differing regulations face severe privacy, regulatory, and logistical obstacles that are often difficult to overcome. The Federated Learning (FL) provides a promising solution by enabling collaborative model training across decentralized datasets while keeping patient data local and private. Here, we report a novel global FL initiative using the Sherpa.ai FL platform, which leverages FL across distributed datasets in two international organizations for the diagnosis of COL6-RD, using collagen VI immunofluorescence microscopy images from patient-derived fibroblast cultures. Our solution resulted in an ML model capable of classifying collagen VI patient images into the three primary pathogenic mechanism groups associated with COL6-RD: exon skipping, glycine substitution, and pseudoexon insertion. This new approach achieved an F1-score of 0.82, outperforming single-organization models (0.57-0.75). These results demonstrate that FL substantially improves diagnostic utility and generalizability compared to isolated institutional models. Beyond enabling more accurate diagnosis, we anticipate that this approach will support the interpretation of variants of uncertain significance and guide the prioritization of sequencing strategies to identify novel pathogenic variants.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>